What Matters to Corporate VCs in 2024?

https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/b1/36/8d/b1368de4-f3ad-0cac-6aa6-e3572beddd43/mza_4184130727494332581.jpg/600x600bb.jpg

Conversations from LSI

LSI

117 episodes

1 week ago

Conversations from LSI brings you the panels, workshops, and key discussions from LSI’s global events—now available on your favorite podcast platforms. Tune in for real insights from the world’s leading medtech and healthtech innovators, investors, and strategics.

Medicine

Health & Fitness

RSS

All content for Conversations from LSI is the property of LSI and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Medicine

Health & Fitness

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/43956871/43956871-1750895889873-443fd0ea935d8.jpg

What Matters to Corporate VCs in 2024? | LSI Europe '24

Conversations from LSI

41 minutes 1 second

1 month ago

What Matters to Corporate VCs in 2024? | LSI Europe '24

This keynote took place at LSI Europe ‘24 Emerging Medtech Summit in Sintra, Portugal.

This panel of corporate VCs dove into the key factors driving investment decisions, from strategic alignment and financial returns to the importance of team dynamics and technological innovation.

This keynote featured:

Ryan Roberts — Veranex

Dan Sheehan — Medtronic

Murielle Thinard McLane — Intuitive Ventures

Colin Morrison — Boston Scientific

Nir Goldenberg — Mayo Clinic

Join us at our next event: https://www.lifesciencemarketresearch.com/why-lsi-summits

LinkedIn: https://www.linkedin.com/company/life-science-intelligence/

Twitter: https://twitter.com/lsintelligence

Instagram: https://www.instagram.com/lifescienceintelligence/

Facebook: https://www.facebook.com/LifeScienceIntelligence/

Subscribe to our YouTube: https://www.youtube.com/channel/UCxAwCTpHCMTScEJbgW7Scjw